Immune modulation by anti-ergotypic regulator peptide

The research was done in collaboration with Dr. Francisco J. Quintana. Clinical applications are being developed by the Israeli company Immune Pharma Limited (Eran Ovadia, CEO).

See the following papers in the list of publications: 203; 270; 418; 435; 459; 493; 494.